Emet Pharmaceuticals LLC is categorized under Wholesale Pharmaceutical Products in Amityville, NY and active since 2003.
Emet Pharmaceuticals LLC was established in 2003, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Steven Roth at the company’s single location by writing to 219 Dixon Avenue, Amityville, New York NY 11701 or by phoning (516) 652-1005. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Emet Pharmaceuticals LLC |
| Contact Person: | Steven Roth |
| Address: | 219 Dixon Avenue, Amityville, New York 11701 |
| Phone Number: | (516) 652-1005 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Emet Pharmaceuticals LLC was started in 2003 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Steven Roth for inquiries that concern Emet Pharmaceuticals LLC by calling the company number (516) 652-1005, as your correspondence is most welcome. Additionally, the physical location of the single location of Emet Pharmaceuticals LLC can be found at the coordinates 40.683719,-73.408653 as well as the street address 219 Dixon Avenue in Amityville, New York 11701.
For its online presence, you may visit Emet Pharmaceuticals LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.